These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30410003)

  • 1. Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes.
    Tokatlian T; Kulp DW; Mutafyan AA; Jones CA; Menis S; Georgeson E; Kubitz M; Zhang MH; Melo MB; Silva M; Yun DS; Schief WR; Irvine DJ
    Sci Rep; 2018 Nov; 8(1):16527. PubMed ID: 30410003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.
    Bale S; Goebrecht G; Stano A; Wilson R; Ota T; Tran K; Ingale J; Zwick MB; Wyatt RT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.
    Morris CD; Azadnia P; de Val N; Vora N; Honda A; Giang E; Saye-Francisco K; Cheng Y; Lin X; Mann CJ; Tang J; Sok D; Burton DR; Law M; Ward AB; He L; Zhu J
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
    Pauthner M; Havenar-Daughton C; Sok D; Nkolola JP; Bastidas R; Boopathy AV; Carnathan DG; Chandrashekar A; Cirelli KM; Cottrell CA; Eroshkin AM; Guenaga J; Kaushik K; Kulp DW; Liu J; McCoy LE; Oom AL; Ozorowski G; Post KW; Sharma SK; Steichen JM; de Taeye SW; Tokatlian T; Torrents de la Peña A; Butera ST; LaBranche CC; Montefiori DC; Silvestri G; Wilson IA; Irvine DJ; Sanders RW; Schief WR; Ward AB; Wyatt RT; Barouch DH; Crotty S; Burton DR
    Immunity; 2017 Jun; 46(6):1073-1088.e6. PubMed ID: 28636956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination.
    Pejawar-Gaddy S; Kovacs JM; Barouch DH; Chen B; Irvine DJ
    Bioconjug Chem; 2014 Aug; 25(8):1470-8. PubMed ID: 25020048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
    Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms.
    Murji AA; Qin JS; Hermanus T; Morris L; Georgiev IS
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
    Sliepen K; Ozorowski G; Burger JA; van Montfort T; Stunnenberg M; LaBranche C; Montefiori DC; Moore JP; Ward AB; Sanders RW
    Retrovirology; 2015 Sep; 12():82. PubMed ID: 26410741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.
    Bricault CA; Kovacs JM; Nkolola JP; Yusim K; Giorgi EE; Shields JL; Perry J; Lavine CL; Cheung A; Ellingson-Strouss K; Rademeyer C; Gray GE; Williamson C; Stamatatos L; Seaman MS; Korber BT; Chen B; Barouch DH
    J Virol; 2015 Mar; 89(5):2507-19. PubMed ID: 25540368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
    Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells.
    Ingale J; Stano A; Guenaga J; Sharma SK; Nemazee D; Zwick MB; Wyatt RT
    Cell Rep; 2016 May; 15(9):1986-99. PubMed ID: 27210756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
    Medina-Ramírez M; Sanders RW; Sattentau QJ
    Curr Opin HIV AIDS; 2017 May; 12(3):241-249. PubMed ID: 28422788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
    Bower JF; Li Y; Wyatt R; Ross TM
    Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
    Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR
    Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus.
    Forsell MN; Li Y; Sundbäck M; Svehla K; Liljeström P; Mascola JR; Wyatt R; Karlsson Hedestam GB
    J Virol; 2005 Sep; 79(17):10902-14. PubMed ID: 16103142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.